Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WE-Study: Botulinum Toxin A for Walking in CP
NCT02546999Phase 4Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Sep 2015
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of botulinum toxin type A in cerebral palsy (CP), Spasticity, sponsored by St. Olavs University Hospital. Started Sep 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)Spasticity
Beyond the preview
Go deeper on NCT02546999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546999.